Use of MAOIs in severe treatment-resistant depression: back to the old school

Use of MAOIs in severe treatment-resistant depression: back to the old school

J Psychiatry Neurosci 2021;46(4):E427-E428 | PDF

Jacob Cookey, MD, MSc


Affiliations: From the Department of Psychiatry, Dalhousie University, Dartmouth, NS, Canada.

Competing interests: None declared.

Content licence: This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is non-commercial (i.e. research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

DOI: 10.1503/jpn.200214